SCHEMBL13065737

SCHEMBL13065737

N#Cc1ccc(-c2c(C(=O)O)c3nc4ccccc4oc-3c(O)c2=O)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 4/20 0.39
MEN1 O00255 6/20 0.38
KMT2A Q03164 6/20 0.38
ATM Q13315 2/20 0.38
LMNA P02545 3/20 0.38
PDE10A Q9Y233 1/20 0.38
MAPT P10636 2/20 0.37
MITF O75030 1/20 0.37
PSMB8 P28062 1/20 0.36
CYP3A4 P08684 3/20 0.36
ALOX15 P16050 3/20 0.36
MAPK1 P28482 3/20 0.36
AR P10275 2/20 0.36
KDM4E B2RXH2 2/20 0.36
TP53 P04637 2/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
ABCB1 P08183 1/20 0.36
CALM1 P0DP23 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065731 0.89 DHODH (0.47) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065738 0.87 HPGD (0.42) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065745 0.86 ABCG2 (0.39) DHODHMEN1KMT2AATMLMNA
SCHEMBL13065732 0.86 MAPK14 (0.45) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065735 0.86 LMNA (0.48) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065585 0.84 SLC16A3 (0.38) DHODHMAPTCYP3A4ALOX15CYP19A1
SCHEMBL13065740 0.83 LMNA (0.39) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065729 0.83 KDM4E (0.51) DHODHMEN1KMT2AATMLMNA
SCHEMBL16784744 0.83 PDE10A (0.40) DHODHMEN1KMT2ALMNAPDE10A
SCHEMBL13065599 0.81 MEN1 (0.41) MEN1KMT2AATMLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 DHODH 3278/4885MEN1 3364/4885KMT2A 4381/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 DHODH 3278/4885MEN1 3364/4885KMT2A 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.